about
Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasisRecent advances in understanding Type 1 DiabetesPredictive models of type 1 diabetes progression: understanding T-cell cycles and their implications on autoantibody releaseAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesEnvironmental risk factors for type 1 diabetesThe pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over timeType 1 diabetes: translating mechanistic observations into effective clinical outcomesPotential viral pathogenic mechanism in human type 1 diabetesResolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Clinical and polysomnographic course of childhood narcolepsy with cataplexy.Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease.Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of diseaseA diagnostic approach for defining idiopathic remitting diabetes: a retrospective cohort study.Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice.A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple SclerosisIslet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetesInduction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.Mig6 haploinsufficiency protects mice against streptozotocin-induced diabetesGPS-MBA: computational analysis of MHC class II epitopes in type 1 diabetesGene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patientsChanges in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunityMapping I-A(g7) restricted epitopes in murine G6PC2.Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes.Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD miceImpact of islet autoimmunity on the progressive β-cell functional decline in type 2 diabetes.GLP-1 could improve the similarity of IPCs and pancreatic beta cells in cellular ultrastructure and function.Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessmentEpigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes.β cell death and dysfunction during type 1 diabetes development in at-risk individuals.Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population.Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 DiabetesModeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses.Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.The pathogenesis and natural history of type 1 diabetes.
P2860
Q24314902-3A11E686-9267-42B3-90D9-0DD4178F56FDQ26766139-B43A3204-CA0F-413E-92BD-33166F6E9BDFQ27312237-9503CC33-D069-48D9-AE0B-7C29D4040D8BQ28080791-E8445D55-E6FE-42CC-AF46-3913FDDBCCAAQ28276366-27AED39A-5643-49A5-BC5E-72432ACC8CFCQ28285897-D7424B86-08FD-4174-BB32-32BAD1483B55Q28287737-2CB09732-DCAA-471A-8EFE-AEAFC96923BCQ28656023-8B4901B0-6B18-43F1-B7A0-C9A624A52FECQ30437086-0A4CFC8D-02EC-4F5A-B460-13E4FA62ABBCQ30559262-8314F980-48FF-4850-8A14-AA84E00064E9Q33659872-D2E9FDCB-C0F9-437B-A883-FAD7C9733188Q33729769-58DA1938-A285-4CBF-B4DF-B27263093614Q33783221-3FFECD1D-51CD-4B54-A43C-BFD4AAFC4C19Q33786819-2AF8D3B4-F4F8-4AAB-9359-36BC6EAE2855Q33789317-6A7B3433-C0CB-4F87-ADCE-F13A5C0FE39DQ33962548-FB7151F8-C1E0-4504-A55F-832A1884ED77Q34016151-1E653C99-A932-4E57-92B2-2BE168E57D92Q34082839-811833C3-7864-405A-A8E3-A219F5C7930AQ34143192-593C9E44-35C0-4764-9F60-2C27F7C727B5Q34221724-6B9B080B-D1FC-4B65-B6F5-B0F2825F0AC9Q34260546-2149A1DA-D0FA-4C7D-9498-0BD245AE3BB7Q34262463-B969543D-180D-41ED-8052-5DC00D1D915DQ34415712-5355C6C2-5B6E-40C7-A2A7-B1EABDA73523Q34514254-29D14307-F50A-4F77-8A5F-BCD8B5912E40Q34527126-ED964233-0011-4B0E-95A1-48B41F331A66Q34545320-F68F53E5-7B3F-48EA-B026-ABB4055E6938Q34647309-98E636A9-E3EA-44ED-8BD0-7503BC5133E8Q35041294-7FF2DF76-BE2E-4FE3-A49C-A06FC0A930B1Q35105316-5073A97A-FBDA-4919-A17F-2F081159B231Q35123513-73E5E044-B612-4871-81EF-906AAC4E5A6AQ35183950-C4D2DB81-9506-40FD-8B98-B9A3E1410C7AQ35630698-99A0D07F-D477-4D17-8CB5-CD6A9FE8E937Q35867243-D245BB32-8EA5-4519-8420-02FB58A43654Q36054301-0A626EA7-E96B-46E6-9341-0C15772FD816Q36186271-099D76EB-802C-457F-8256-167927CE8FF6Q36206778-E9F3F896-84E8-4116-8D71-733537FA3132Q36278041-796A1CD3-D925-446A-AC8B-F5C5036745A4Q36292592-9C19B265-2CF9-43BF-BF99-77D7DA6A53E6Q36460478-08E76EEC-2F85-4B34-964B-EF6499F111C2Q36526611-DFDB9ABF-D0C1-4F7A-A24C-35736A3EDDE7
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Type 1 diabetes as a relapsing-remitting disease?
@en
type
label
Type 1 diabetes as a relapsing-remitting disease?
@en
prefLabel
Type 1 diabetes as a relapsing-remitting disease?
@en
P2093
P356
P1476
Type 1 diabetes as a relapsing-remitting disease?
@en
P2093
Kevan Herold
Matthias von Herrath
Srinath Sanda
P304
P356
10.1038/NRI2192
P577
2007-12-01T00:00:00Z